Philips Launches AI-Driven ECG Marketplace for Smarter Cardiac Care

Anumana, an AI health tech firm, is the first to join Philips’ ECG AI Marketplace with its FDA-cleared ECG-AI LEF algorithm, aimed at advancing cardiac care.

Royal Philips, a global leader in health technology, has announced the launch of the Philips ECG AI Marketplace, expanding its cardiac diagnostic ecosystem through an open platform.

The platform gives cardiac care teams access to multiple vendor offerings, simplifying the management and implementation of AI-powered diagnostic tools.

Anumana, an AI health tech firm, is the first to join Philips’ ECG AI Marketplace with its FDA-cleared ECG-AI LEF algorithm, aimed at advancing cardiac care.

The LEF algorithm analyzes a standard 12-lead resting ECG to identify reduced ejection fraction, an early indicator of heart failure.

The AI-powered tool enables U.S. hospitals and health systems to seamlessly integrate validated algorithms into their existing Philips infrastructure and workflows.

Additionally, the Marketplace also gives cardiac care teams direct access to a broad portfolio of AI tools at the point of care, helping reduce the time it takes for clinicians to review ECG results and fast-track diagnoses for patients.

Stefano Folli, Business Leader, Ambulatory Monitoring and Diagnostics, Philips said, “The Philips ECG AI Marketplace meets a growing need for easier access and management of AI-enabled tools to improve the healthcare experience for clinicians and patients. Our collaboration with Anumana is a strong example of how these tools can support both earlier detection of heart diseases and accelerate patient care.”

With this collaboration with Anumana, Philips aims to expand its ECG platform to integrate third-party AI tools, supporting clinical decisions and early detection of heart conditions.

Stay tuned for more such updates on Digital Health News